Study Stopped
Funding ended before the second phase of the study could be started. Additionally, the second phase of the study will be a part of the PIs K01 study.
Storytelling Intervention for African Americans Living With Hypertension
Developing and Implementing a Storytelling Intervention for African Americans Living With Hypertension
2 other identifiers
interventional
31
1 country
1
Brief Summary
Narrative communication (e.g., storytelling) is an approach that has contributed to behavioral change for individuals with conditions such as diabetes, breast cancer, and hypertension. The objective of this study is to conduct a feasibility and pilot study storytelling intervention for African Americans with hypertension. In the feasibility phase 30 African Americans with hypertension will be recruited to view nine patient stories and provide feedback on the effectiveness, usefulness, and satisfaction with the stories. Nine African Americans adults with hypertension were filmed, sharing experiences living with and managing hypertension; including, diet and exercise tips, suggestions for locating healthy foods, and motivational stories about successfully controlling hypertension. During the feasibility phase feedback will also be elicited from the participants about the best approaches for delivering a storytelling intervention, and obtain feedback on the resources and health information that would be helpful to an individual participating in a storytelling intervention. In the pilot study phase, 30 African Americans adults with hypertension will be recruited to participate in a 6-week trial, each week the participants will watch one story and review one module of health information accessible through the study specific website developed for the High Blood Pressure Stories (HBPStories) study. Data will be collected at baseline and 6-weeks including systolic and diastolic blood pressure, medication adherence, health behaviors such as diet and physical activity, and psychosocial measures including positive affect and self-efficacy in the management of hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Jul 2022
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2022
CompletedFirst Submitted
Initial submission to the registry
August 31, 2022
CompletedFirst Posted
Study publicly available on registry
October 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2023
CompletedResults Posted
Study results publicly available
September 19, 2024
CompletedOctober 8, 2024
June 1, 2024
12 months
August 31, 2022
April 29, 2024
September 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Blood Pressure
Systolic and Diastolic Blood Pressure, Unit of Measure: Percentage of Individuals with Elevated or High Blood Pressure
6 weeks
Medication Adherence
Self-reported medication adherence, Unit of Measure: Percentage of Individuals reporting low, moderate, or high adherence
6 weeks
Other Outcomes (1)
Effectiveness and Engagement
baseline
Study Arms (2)
Pilot Study
EXPERIMENTALThe objective of the second phase of the study was to conduct a 6-week pilot study of the web-based storytelling approach
Feasibility Phase
NO INTERVENTIONThe objective of the feasibility phase was to assess participant views of the stories and the study website, and obtain feedback for the design of a future trial.
Interventions
The objective of this arm was to pilot test the web-based storytelling program to determine the preliminary impact on blood pressure and medication adherence, and if the web-based approach was an engaging approach for individuals managing hypertension.
Eligibility Criteria
You may qualify if:
- self-reported hypertension
- race/ethnicity: Black or African American
- prescribed antihypertensive medication
- age ≥ 18 years
You may not qualify if:
- cognitive limitations that limit the ability to provide informed consent
- unable to speak or read English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Delaware
Newark, Delaware, 19713, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Recruitment for the feasibility study was delayed and we were able to recruit participants for the first phase of the study. The second phase of the study was not completed, the 6-week trial. However, the study was recently funded and the 6 week trial will be conducted as a part of a pilot study.
Results Point of Contact
- Title
- Dr. Yendelela Cuffee
- Organization
- University of Delaware
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2022
First Posted
October 26, 2022
Study Start
July 14, 2022
Primary Completion
June 24, 2023
Study Completion
June 24, 2023
Last Updated
October 8, 2024
Results First Posted
September 19, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The de-identified study data will become available one year after the last participant is recruited, and will be available for three years. Supporting information will be available as soon as recruitment is completed.
- Access Criteria
- Please email the PI for access to study data and supporting information.
De-identified participant data will be available one year after the last participant is recruited. Study protocol, informed consent, and study surveys will be available immediately after recruitment is completed.